CELH
Celsius Holdings, Inc.
CELH has the edge over MNST overall, supported by stronger valuation and stronger fundamentals.
MNST
Monster Beverage Corporation
MNST has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MNST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MNST's revenue, profitability, cash flow and balance sheet are all currently healthy.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over MNST in the historical PE scenario, which offers more potential upside but is not a forecast.
MNST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 32x | $35.43 | -22% |
| Forward | 36x | $45.57 | — |
| Fair | 38x | $41.36 | -9.2% |
| Current | 41x | $45.57 | — |
| Expensive | 43x | $47.63 | +4.5% |
Historical ranges are pointers, not guarantees.
MNST's PE is in its expensive range at 41x. If earnings grow as analysts expect, today's price would be 36x next year's earnings, in its fair range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over MNST on the outlook, with more favorable profitability expectations.
MNST Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MNST, with profitability holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
MNST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.26 | +15% |
| Q3 2026 | $1.10 | +25% |
| Q2 2026 | $1.08 | +33% |
| Q1 2026 | $1.03 | +36% |
| Q4 2025 | $0.97 | +31% |
| Q3 2025 | $0.88 | +13% |
| Q2 2025 | $0.81 | +1.2% |
| Q1 2025 | $0.76 | -3.8% |
| Q4 2024 | $0.74 | -3.9% |
MNST has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
MNST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +17% |
| Q2 2026 | $2.5B | +20% |
| Q1 2026 | $2.4B | +27% |
| Q4 2025 | $2.1B | +18% |
| Q3 2025 | $2.2B | +17% |
| Q2 2025 | $2.1B | +11% |
| Q1 2025 | $1.9B | -2.3% |
| Q4 2024 | $1.8B | +4.7% |
MNST's revenue has grown year over year for six quarters in a row: $2.6B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | -2.7 points |
| Q2 2026 | 29% | -0.7 points |
| Q1 2026 | 31% | +0.3 points |
| Q4 2025 | 25% | +4.4 points |
| Q3 2025 | 31% | +5.2 points |
| Q2 2025 | 30% | +2.2 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 21% | -4 points |
MNST has the edge over CELH on profitability, with a higher operating margin.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
MNST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $525M | -25% |
| Q2 2026 | $460.8M | +6% |
| Q1 2026 | $584.4M | +22% |
| Q4 2025 | $351.2M | -5.2% |
| Q3 2025 | $701.5M | +23% |
| Q2 2025 | $434.6M | +15% |
| Q1 2025 | $478.5M | +38% |
| Q4 2024 | $370.4M | +15% |
MNST has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over MNST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
MNST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.5% | +10.2M shares |
| 3 years | -6.6% | -140M shares |
| 5 years | -7.6% | -164M shares |
| Available history | -9.4% | -206M shares |
MNST has 2B diluted shares, up 0.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100.4M |
| Q2 2026 | $8,000 |
| Q1 2026 | $134M |
| Q4 2025 | $59.7M |
| Q3 2025 | $27.3M |
| Q2 2025 | — |
| Q1 2025 | $16.6M |
| Q4 2024 | $1.7M |
MNST spent $294M buying back its own shares over the past year, about six times what it spent the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
MNST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
| Q2 2024 | -0.4x | Net Cash |
| Q1 2024 | -1.2x | Net Cash |
MNST has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
MNST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 60.6 | Neutral |
MNST's weekly RSI is 53 (neutral) and its Stochastic is 61 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over MNST on valuation relative to its sector.
MNST PE vs Consumer Defensive Sector
| Metric | MNST | Sector median | Relative |
|---|---|---|---|
| PE | 41x | 19x | 112% above |
| PE % | 74 | 18 | 56 pts above |
MNST is trading at 41x earnings, a 112% premium to the Consumer Defensive sector's median of 19x.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
MNST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $45.0 | 1.2% above |
| 20 week MA | $46.0 | 0.9% below |
| 50 week MA | $42.7 | 6.8% above |
| 100 week MA | $36.4 | 25% above |
| 200 week MA | $31.7 | 44% above |
MNST has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
MNST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.9 | $22.5 | +41% |
| 2021 | $22.5 | $23.5 | +4.5% |
| 2022 | $23.5 | $25.3 | +7.9% |
| 2023 | $25.3 | $28.8 | +14% |
| 2024 | $28.8 | $26.3 | -8.8% |
| 2025 | $26.3 | $38.7 | +47% |
| 2026 YTD | $38.7 | $45.6 | +18% |
MNST has the edge over CELH on returns for 2026, with the stronger performance.